ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 358

Emergency Department Encounters in a Large US Payer Database: Tophaceous versus Non-tophaceous Gout Patients

Meron Mezgebe1, Megan Francis-Sedlak 1, Brian LaMoreaux 1 and Robert Holt 1, 1Horizon Therapeutics plc, Lake Forest, IL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: emergency and comorbidity, gout, payers, tophaceous gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Metabolic & Crystal Arthropathies Poster I: Clinical

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: From 2006 to 2012, gout was the primary indication for ~0.2% of all emergency department visits for adults, as reported in the Nationwide Emergency Department Sample (NEDS).1 The rate of emergency department visits for gout in the NEDS increased by 14% between 2006 and 2012 rising from 75.0 to 85.4 per 100,000 US adults.1 A cross-sectional study of 296 gout patients reported that a composite gout severity score, composed of mean serum uric acid, patient-rated and physician-rated gout severity, was a significant predictor of emergency/urgent care service utilization for gout treatment.2 The relationship between the presence or absence of tophi, visible monosodium urate crystal masses representing an uncontrolled stage of gout,3 and emergency department utilization has not been previously reported. The objectives of this study were to analyze the utilization of emergency department services and compare the diagnostic codes present among tophaceous and non-tophaceous gout patients.

Methods: A retrospective review of Humana Research Database data from 2007 to 2017 in private pay and Medicare patients was performed to identify patients with at least 1 gout ICD-9 diagnosis code and enrolled in the plan for at least 6 months (N=370,484). Patients were divided by gout codes into patients with at least one tophi code (tophaceous group) and patients without any tophi codes (non-tophaceous group). To decrease bias non-tophaceous patients were matched to tophaceous patients based on age, gender and race. Relevant comorbidity codes were grouped and examined. Occurrence of ICD codes during emergency department encounters were analyzed in the two groups.

Results: The tophaceous and non-tophaceous group included 6,889 patients each. The patients were mean age 70.7 years, 69.4% male, and 71.7% white. Patients in the tophaceous group had a shorter time in plan since gout diagnosis (average of 3.3 years) compared to non-tophaceous patients (average 3.7 years in plan). During the time in plan analyzed, more patients with tophaceous gout had at least one emergency department encounter than patients without tophi (71.2% tophaceous vs. 67.4% non-tophaceous; OR 1.19, 95%CI of 1.109 to 1.282, p< 0.001). On average, during this period, patients with tophi had 4.01 visits to the emergency department and the patients without tophi had 3.51.The percentage of patients with renal and cardiovascular comorbid emergency department codes were increased in the tophaceous group. Table 1 compares the percentage of patients with and without tophi with emergency department codes.

Conclusion: In this large matched database study more patients with visibly tophaceous gout had at least one emergency department encounter during the time in plan analyzed as compared with their non-tophaceous gout counterparts. Additionally, patients with tophi had a greater number of emergency department encounters in this time period. In these encounters renal and cardiovascular complications were increased in the tophaceous group.


Table 1. ICD- Codes during an Emergency Department Encounter

Table 1. ICD- Codes during an Emergency Department Encounter


Disclosure: M. Mezgebe, Horizon Therapeutics, 3, 9; M. Francis-Sedlak, Horizon, 3, 4, Horizon Therapeutics, 3, 4; B. LaMoreaux, Horizon, 3, 4; R. Holt, Horizon, 3, 4, Horizon Therapeutics, 3, 4.

To cite this abstract in AMA style:

Mezgebe M, Francis-Sedlak M, LaMoreaux B, Holt R. Emergency Department Encounters in a Large US Payer Database: Tophaceous versus Non-tophaceous Gout Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/emergency-department-encounters-in-a-large-us-payer-database-tophaceous-versus-non-tophaceous-gout-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/emergency-department-encounters-in-a-large-us-payer-database-tophaceous-versus-non-tophaceous-gout-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology